CLINICAL_TRIALS
trial_result
· 2013-08-29
Clinical Trial Update: A Study to Evaluate the Safety of Apixaban in Acute Coronary Syndrome (ACS) Japanese Patients [Phase 2]
Summary
A Phase 2 study evaluating the safety of apixaban in Japanese patients with acute coronary syndrome was terminated, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Acute Coronary Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2013-08-29